Aspirin: cancer prevention benefits outweigh risks for 55-75 age group
Added: Thursday 8 March 2012
US research suggests that for people aged 55 to 75, the risks of taking aspirin outweigh the cancer prevention benefits. Aspirin is well-known for being associated with gastrointestinal bleeding, but recent research also links it to macular degeneration. The authors of a recent analysis
concluded that healthy people do not experience any significant
reduction in either cardiovascular or cancer deaths when they take
aspirin. Research in the area of secondary prevention is ongoing.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: